Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study

Food and Healthcare Press Releases Monday September 11, 2017 15:51
LAUSANNE, Switzerland--11 Sep--PRNewswire/InfoQuest
Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published in the Journal of Drugs in Dermatology.
(Logo: http://mma.prnewswire.com/media/554005/Galderma_Logo.jpg )

"This is the first study evaluating the benefit of using both ivermectin 1% and brimonidine 0.33% in combination to effectively target the multiple features of rosacea," commented study author Linda Stein Gold, Henry Ford Hospital, Detroit, MI. "This study develops a comprehensive and early treatment approach to this complex disease."

"The visible signs of rosacea can significantly impact patients' quality of life," said Gregor Schaefer, Medical Lead at Galderma. "Galderma is committed to supporting patients through the development of practical treatment options."

Reference:
Stein Gold L, et al. J Drugs Dermatol. 2017;16(9):909-916.
About Rosacea

Rosacea is a common inflammatory skin disease that presents variable clinical characteristics, of which the most common are flushing, permanent erythema, and inflammatory lesions. It mainly affects the central areas of the face, such as the cheeks and nose. The disease can affect both adult men and women, usually after the age of 30. Additionally, symptoms such as stinging, burning and increased sensitivity of the skin are common. The eyes are often affected, and might present as red, dry or itchy.

Although the cause of the disease is still under debate, various trigger factors are known, including spicy foods, alcohol, emotional stress, sun/UV-exposure, hot baths and beverages. Demodex, generally harmless mites, can also be found in the skin in an elevated quantity in people with rosacea.

Rosacea may worsen over time if left untreated. People that suspect they suffer from rosacea should visit their dermatologist or healthcare provider for diagnosis and discuss what treatment is right for them. Because rosacea is a highly visible disease, it is known to cause embarrassment and anxiety in some patients, which in turn may cause frustration and have a negative impact on their social life.

About Galderma

Galderma, Nestle Skin Health's medical solutions business, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically defined and medically proven solutions for the skin, hair and nails. For more information, please visit http://www.galderma.com

Source: Galderma

Latest Press Release

The Consumer Health of Merck Walks the Talk with its WE100 Movement

- Consumer Health accelerates its WE100(R) movement by launching new partnership programme with pharmacists in the UK on enabling 100 years of healthy living - Femibion(R) celebrates working mums with new "MumPlus" campaign - Expansion of Vitamin D brand...

Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport

The revolutionary transport solution extends intelligent monitoring to out-of-hospital transport settings such as ambulances, helicopters, and civic flights. Mindray, a global medical equipment solution provider, announced the release of BeneVision N1...

Photo Release: Fujitsu works with the Thai Red Cross Society to contribute to society through the annual 20th FTH Voluntary Blood Donation Day

Ms. Krittinee Sivakul, Head of HR & Administration Group, Fujitsu (Thailand) Co., Ltd. (FTH) led a group comprising company management and staff at a special executives and 187 employees of the company recently donated blood to the Thai Red Cross...

Systech Europe(TM) Announces Rapid Expansion of Customer Base and Pharmaceutical Serialisation Partners Ready to Meet the FMD Regulation

Systech International , the global technology leader in serialisation, track and trace, and brand protection grew its European presence in 2017 by 50% with new accounts in France, Germany, Greece, Turkey, and Finland. The company also added new...

Fluke Biomedical VT650 and VT900 Gas Flow Analyzers offer the highest accuracy on the market

New analyzers deliver ease-of-use and reliability in measurements for all types of ventilators, flow meters, pressure gauges, anesthesia machines, and other devices Fluke Biomedical introduces the VT650 and VT900 Gas Flow Analyzers , which include...

Related Topics